메뉴 건너뛰기




Volumn 40, Issue 2, 2014, Pages 215-219

Human papilloma virus positive oropharyngeal squamous cell carcinoma: A growing epidemic

Author keywords

Human papilloma virus; Management; Oropharyngeal squamous cell carcinoma; Pathogenesis

Indexed keywords

CARBOPLATIN; CETUXIMAB; CISPLATIN; DOCETAXEL; FLUOROURACIL; PACLITAXEL; PROTEIN P16; PROTEIN P53;

EID: 84888305913     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2013.09.006     Document Type: Review
Times cited : (69)

References (48)
  • 2
    • 39149104081 scopus 로고    scopus 로고
    • Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States
    • Chaturvedi A.K., Engels E.A., Anderson W.F., Gillison M.L. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008, 26(4):612-619.
    • (2008) J Clin Oncol , vol.26 , Issue.4 , pp. 612-619
    • Chaturvedi, A.K.1    Engels, E.A.2    Anderson, W.F.3    Gillison, M.L.4
  • 3
    • 84888305514 scopus 로고    scopus 로고
    • HPV associated oropharyngeal cancer rates by race and ethnicity [Internet]. Available from
    • HPV associated oropharyngeal cancer rates by race and ethnicity [Internet]. Available from: http://www.cdc.gov/cancer/hpv/statistics/headneck.htm.
  • 4
  • 5
    • 84863975396 scopus 로고    scopus 로고
    • Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer
    • Gillison M.L., Zhang Q., Jordan R., Xiao W., Westra W.H., Trotti A., et al. Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol 2012, 30(17):2102-2111.
    • (2012) J Clin Oncol , vol.30 , Issue.17 , pp. 2102-2111
    • Gillison, M.L.1    Zhang, Q.2    Jordan, R.3    Xiao, W.4    Westra, W.H.5    Trotti, A.6
  • 7
    • 0024535277 scopus 로고
    • Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation
    • Hinds P., Finlay C., Levine A.J. Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation. J Virol 1989, 63(2):739-746.
    • (1989) J Virol , vol.63 , Issue.2 , pp. 739-746
    • Hinds, P.1    Finlay, C.2    Levine, A.J.3
  • 9
    • 0027358723 scopus 로고
    • The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
    • Scheffner M., Huibregtse J.M., Vierstra R.D., Howley P.M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993, 75(3):495-505.
    • (1993) Cell , vol.75 , Issue.3 , pp. 495-505
    • Scheffner, M.1    Huibregtse, J.M.2    Vierstra, R.D.3    Howley, P.M.4
  • 10
    • 0029029938 scopus 로고
    • P53 inactivation by HPV16 E6 results in increased mutagenesis in human cells
    • Havre P.A., Yuan J., Hedrick L., Cho K.R., Glazer P.M. p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells. Cancer Res 1995, 55(19):4420-4424.
    • (1995) Cancer Res , vol.55 , Issue.19 , pp. 4420-4424
    • Havre, P.A.1    Yuan, J.2    Hedrick, L.3    Cho, K.R.4    Glazer, P.M.5
  • 11
    • 0033578418 scopus 로고    scopus 로고
    • Regulation of the Src family tyrosine kinase Blk through E6AP-mediated ubiquitination
    • Oda H., Kumar S., Howley P.M. Regulation of the Src family tyrosine kinase Blk through E6AP-mediated ubiquitination. Proc Natl Acad Sci USA 1999, 96(17):9557-9562.
    • (1999) Proc Natl Acad Sci USA , vol.96 , Issue.17 , pp. 9557-9562
    • Oda, H.1    Kumar, S.2    Howley, P.M.3
  • 12
    • 0026705926 scopus 로고
    • Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16-immortalized cells
    • Pagano M., Durst M., Joswig S., Draetta G., Jansen-Durr P. Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16-immortalized cells. Oncogene 1992, 7(9):1681-1686.
    • (1992) Oncogene , vol.7 , Issue.9 , pp. 1681-1686
    • Pagano, M.1    Durst, M.2    Joswig, S.3    Draetta, G.4    Jansen-Durr, P.5
  • 14
    • 0028325483 scopus 로고
    • Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7
    • Demers G.W., Foster S.A., Halbert C.L., Galloway D.A. Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7. Proc Natl Acad Sci USA 1994, 91(10):4382-4386.
    • (1994) Proc Natl Acad Sci USA , vol.91 , Issue.10 , pp. 4382-4386
    • Demers, G.W.1    Foster, S.A.2    Halbert, C.L.3    Galloway, D.A.4
  • 15
    • 32944464047 scopus 로고    scopus 로고
    • Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma
    • Slebos R.J., Yi Y., Ely K., Carter J., Evjen A., Zhang X., et al. Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin Cancer Res 2006, 12(3 Pt 1):701-709.
    • (2006) Clin Cancer Res , vol.12 , Issue.3 PART 1 , pp. 701-709
    • Slebos, R.J.1    Yi, Y.2    Ely, K.3    Carter, J.4    Evjen, A.5    Zhang, X.6
  • 16
    • 42249105032 scopus 로고    scopus 로고
    • Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells
    • Martinez I., Gardiner A.S., Board K.F., Monzon F.A., Edwards R.P., Khan S.A. Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene 2008, 27(18):2575-2582.
    • (2008) Oncogene , vol.27 , Issue.18 , pp. 2575-2582
    • Martinez, I.1    Gardiner, A.S.2    Board, K.F.3    Monzon, F.A.4    Edwards, R.P.5    Khan, S.A.6
  • 17
    • 33751038688 scopus 로고    scopus 로고
    • 11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours
    • Ragin C.C., Taioli E., Weissfeld J.L., White J.S., Rossie K.M., Modugno F., et al. 11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours. Br J Cancer 2006, 95(10):1432-1438.
    • (2006) Br J Cancer , vol.95 , Issue.10 , pp. 1432-1438
    • Ragin, C.C.1    Taioli, E.2    Weissfeld, J.L.3    White, J.S.4    Rossie, K.M.5    Modugno, F.6
  • 18
    • 34548680936 scopus 로고    scopus 로고
    • Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis
    • Ragin C.C., Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer 2007, 121(8):1813-1820.
    • (2007) Int J Cancer , vol.121 , Issue.8 , pp. 1813-1820
    • Ragin, C.C.1    Taioli, E.2
  • 20
    • 83955164347 scopus 로고    scopus 로고
    • A typical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy
    • Huang S.H., Perez-Ordonez B., Liu F.F., Waldron J., Ringash J., Irish J., et al. A typical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 2012, 82(1):276-283.
    • (2012) Int J Radiat Oncol Biol Phys , vol.82 , Issue.1 , pp. 276-283
    • Huang, S.H.1    Perez-Ordonez, B.2    Liu, F.F.3    Waldron, J.4    Ringash, J.5    Irish, J.6
  • 21
    • 84888291008 scopus 로고    scopus 로고
    • NCCN clinical practice guidelines in oncology. Head and neck cancers. Version 2.2013 [Internet], 2013:06/09.
    • NCCN clinical practice guidelines in oncology. Head and neck cancers. Version 2.2013 [Internet], 2013:06/09.
  • 22
    • 84864117653 scopus 로고    scopus 로고
    • Epidemiology and clinical aspects of HPV in head and neck cancers
    • Chaturvedi A.K. Epidemiology and clinical aspects of HPV in head and neck cancers. Head Neck Pathol 2012, 6(Suppl 1):S16-S24.
    • (2012) Head Neck Pathol , vol.6 , Issue.SUPPL 1
    • Chaturvedi, A.K.1
  • 24
    • 67650354892 scopus 로고    scopus 로고
    • Human papillomavirus-related head and neck tumors: clinical and research implication
    • Psyrri A., Gouveris P., Vermorken J.B. Human papillomavirus-related head and neck tumors: clinical and research implication. Curr Opin Oncol 2009, 21(3):201-205.
    • (2009) Curr Opin Oncol , vol.21 , Issue.3 , pp. 201-205
    • Psyrri, A.1    Gouveris, P.2    Vermorken, J.B.3
  • 25
    • 84863196741 scopus 로고    scopus 로고
    • Survival in patients with human papillomavirus positive tonsillar cancer in relation to treatment
    • Attner P., Nasman A., Du J., Hammarstedt L., Ramqvist T., Lindholm J., et al. Survival in patients with human papillomavirus positive tonsillar cancer in relation to treatment. Int J Cancer 2012, 131(5):1124-1130.
    • (2012) Int J Cancer , vol.131 , Issue.5 , pp. 1124-1130
    • Attner, P.1    Nasman, A.2    Du, J.3    Hammarstedt, L.4    Ramqvist, T.5    Lindholm, J.6
  • 26
    • 79953124785 scopus 로고    scopus 로고
    • The role of human papillomavirus in the pathogenesis of head & neck squamous cell carcinoma: an overview
    • Pannone G., Santoro A., Papagerakis S., Lo Muzio L., De Rosa G., Bufo P. The role of human papillomavirus in the pathogenesis of head & neck squamous cell carcinoma: an overview. Infect Agent Cancer 2011, 6(4). 10.1186/1750-9378-6-4.
    • (2011) Infect Agent Cancer , vol.6 , Issue.4
    • Pannone, G.1    Santoro, A.2    Papagerakis, S.3    Lo Muzio, L.4    De Rosa, G.5    Bufo, P.6
  • 27
    • 65349173893 scopus 로고    scopus 로고
    • Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck
    • Lassen P., Eriksen J.G., Hamilton-Dutoit S., Tramm T., Alsner J., Overgaard J. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol 2009, 27(12):1992-1998.
    • (2009) J Clin Oncol , vol.27 , Issue.12 , pp. 1992-1998
    • Lassen, P.1    Eriksen, J.G.2    Hamilton-Dutoit, S.3    Tramm, T.4    Alsner, J.5    Overgaard, J.6
  • 28
    • 79960367969 scopus 로고    scopus 로고
    • The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomized DAHANCA 6&7 trial
    • Lassen P., Eriksen J.G., Krogdahl A., Therkildsen M.H., Ulhoi B.P., Overgaard M., et al. The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomized DAHANCA 6&7 trial. Radiother Oncol 2011, 100(1):49-55.
    • (2011) Radiother Oncol , vol.100 , Issue.1 , pp. 49-55
    • Lassen, P.1    Eriksen, J.G.2    Krogdahl, A.3    Therkildsen, M.H.4    Ulhoi, B.P.5    Overgaard, M.6
  • 29
    • 39649109915 scopus 로고    scopus 로고
    • Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial
    • Fakhry C., Westra W.H., Li S., Cmelak A., Ridge J.A., Pinto H., et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008, 100(4):261-269.
    • (2008) J Natl Cancer Inst , vol.100 , Issue.4 , pp. 261-269
    • Fakhry, C.1    Westra, W.H.2    Li, S.3    Cmelak, A.4    Ridge, J.A.5    Pinto, H.6
  • 30
    • 79955514313 scopus 로고    scopus 로고
    • Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial
    • Posner M.R., Lorch J.H., Goloubeva O., Tan M., Schumaker L.M., Sarlis N.J., et al. Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial. Ann Oncol 2011, 22(5):1071-1077.
    • (2011) Ann Oncol , vol.22 , Issue.5 , pp. 1071-1077
    • Posner, M.R.1    Lorch, J.H.2    Goloubeva, O.3    Tan, M.4    Schumaker, L.M.5    Sarlis, N.J.6
  • 31
    • 77957955293 scopus 로고    scopus 로고
    • Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial
    • Rischin D., Young R.J., Fisher R., Fox S.B., Le Q.T., Peters L.J., et al. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol 2010, 28(27):4142-4148.
    • (2010) J Clin Oncol , vol.28 , Issue.27 , pp. 4142-4148
    • Rischin, D.1    Young, R.J.2    Fisher, R.3    Fox, S.B.4    Le, Q.T.5    Peters, L.J.6
  • 32
    • 84884135749 scopus 로고    scopus 로고
    • ECOG 1308: a phase II trial of induction chemotherapy followed by cetuximab with low dose versus standard dose IMRT in patients with HPV-associated resectable squamous cell carcinoma of the oropharynx (OP). 2012 ASCO annual meeting
    • Marur S, Lee J, Cmelak A, Zhao W, Westra W, Chung C, et al. ECOG 1308: a phase II trial of induction chemotherapy followed by cetuximab with low dose versus standard dose IMRT in patients with HPV-associated resectable squamous cell carcinoma of the oropharynx (OP). 2012 ASCO annual meeting. J Clin Oncol 2012.
    • (2012) J Clin Oncol
    • Marur, S.1    Lee, J.2    Cmelak, A.3    Zhao, W.4    Westra, W.5    Chung, C.6
  • 33
    • 84869507343 scopus 로고    scopus 로고
    • Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee clinical trials planning meeting, November 6-7, 2011, Arlington, Virginia
    • Adelstein D.J., Ridge J.A., Brizel D.M., Holsinger F.C., Haughey B.H., O'Sullivan B., et al. Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee clinical trials planning meeting, November 6-7, 2011, Arlington, Virginia. Head Neck 2012, 34(12):1681-1703.
    • (2012) Head Neck , vol.34 , Issue.12 , pp. 1681-1703
    • Adelstein, D.J.1    Ridge, J.A.2    Brizel, D.M.3    Holsinger, F.C.4    Haughey, B.H.5    O'Sullivan, B.6
  • 34
    • 84888301476 scopus 로고    scopus 로고
    • RTOG 1016 protocol information: Phase III trial of radiotherapy plus cetuximab versus chemoradiotherapy in HPV-associated oropharynx cancer [Internet]; 2013. Available from:
    • RTOG 1016 protocol information: Phase III trial of radiotherapy plus cetuximab versus chemoradiotherapy in HPV-associated oropharynx cancer [Internet]; 2013. Available from: http://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=1016.
  • 35
    • 84888293599 scopus 로고    scopus 로고
    • Phase II randomized trial of transoral surgical resection followed by low- dose or standard dose IMRT in resectable p16+ locally advanced oropharynx cancer [Internet]; Aug 2013. Available from:
    • Phase II randomized trial of transoral surgical resection followed by low- dose or standard dose IMRT in resectable p16+ locally advanced oropharynx cancer [Internet]; Aug 2013. Available from: http://ecog-acrin.org/trials/head-and-neck.
  • 36
    • 79958272187 scopus 로고    scopus 로고
    • Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study
    • Haughey B.H., Hinni M.L., Salassa J.R., Hayden R.E., Grant D.G., Rich J.T., et al. Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study. Head Neck 2011, 33(12):1683-1694.
    • (2011) Head Neck , vol.33 , Issue.12 , pp. 1683-1694
    • Haughey, B.H.1    Hinni, M.L.2    Salassa, J.R.3    Hayden, R.E.4    Grant, D.G.5    Rich, J.T.6
  • 37
    • 84875318185 scopus 로고    scopus 로고
    • Transoral surgery alone for human-papillomavirus-associated oropharyngeal squamous cell carcinoma
    • Olsen S.M., Moore E.J., Laborde R.R., Garcia J.J., Janus J.R., Price D.L., et al. Transoral surgery alone for human-papillomavirus-associated oropharyngeal squamous cell carcinoma. Ear Nose Throat J 2013, 92(2):76-83.
    • (2013) Ear Nose Throat J , vol.92 , Issue.2 , pp. 76-83
    • Olsen, S.M.1    Moore, E.J.2    Laborde, R.R.3    Garcia, J.J.4    Janus, J.R.5    Price, D.L.6
  • 39
    • 84874407327 scopus 로고    scopus 로고
    • Transoral robotic surgery and adjuvant therapy for oropharyngeal carcinomas and the influence of p16 INK4a on treatment outcomes
    • Quon H., Cohen M.A., Montone K.T., Ziober A.F., Wang L.P., Weinstein G.S., et al. Transoral robotic surgery and adjuvant therapy for oropharyngeal carcinomas and the influence of p16 INK4a on treatment outcomes. Laryngoscope 2013, 123(3):635-640.
    • (2013) Laryngoscope , vol.123 , Issue.3 , pp. 635-640
    • Quon, H.1    Cohen, M.A.2    Montone, K.T.3    Ziober, A.F.4    Wang, L.P.5    Weinstein, G.S.6
  • 40
    • 84855646939 scopus 로고    scopus 로고
    • Transoral robotic surgery for oropharyngeal carcinoma and its impact on patient-reported quality of life and function
    • Leonhardt F.D., Quon H., Abrahao M., O'Malley B.W., Weinstein G.S. Transoral robotic surgery for oropharyngeal carcinoma and its impact on patient-reported quality of life and function. Head Neck 2012, 34(2):146-154.
    • (2012) Head Neck , vol.34 , Issue.2 , pp. 146-154
    • Leonhardt, F.D.1    Quon, H.2    Abrahao, M.3    O'Malley, B.W.4    Weinstein, G.S.5
  • 41
    • 77956573724 scopus 로고    scopus 로고
    • Selective neck dissection and deintensified postoperative radiation and chemotherapy for oropharyngeal cancer: a subset analysis of the University of Pennsylvania transoral robotic surgery trial
    • Weinstein G.S., Quon H., O'Malley B.W., Kim G.G., Cohen M.A. Selective neck dissection and deintensified postoperative radiation and chemotherapy for oropharyngeal cancer: a subset analysis of the University of Pennsylvania transoral robotic surgery trial. Laryngoscope 2010, 120(9):1749-1755.
    • (2010) Laryngoscope , vol.120 , Issue.9 , pp. 1749-1755
    • Weinstein, G.S.1    Quon, H.2    O'Malley, B.W.3    Kim, G.G.4    Cohen, M.A.5
  • 42
    • 84875061795 scopus 로고    scopus 로고
    • Early-stage squamous cell carcinoma of the oropharynx: radiotherapy vs. trans-oral robotic surgery (ORATOR) - study protocol for a randomized phase II trial
    • Nichols A.C., Yoo J., Hammond J.A., Fung K., Winquist E., Read N., et al. Early-stage squamous cell carcinoma of the oropharynx: radiotherapy vs. trans-oral robotic surgery (ORATOR) - study protocol for a randomized phase II trial. BMC Cancer 2013, 13(133). 10.1186/1471-2407-13-133.
    • (2013) BMC Cancer , vol.13 , Issue.133
    • Nichols, A.C.1    Yoo, J.2    Hammond, J.A.3    Fung, K.4    Winquist, E.5    Read, N.6
  • 43
    • 84875421186 scopus 로고    scopus 로고
    • Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis
    • O'Sullivan B., Huang S.H., Siu L.L., Waldron J., Zhao H., Perez-Ordonez B., et al. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. J Clin Oncol 2013, 31(5):543-550.
    • (2013) J Clin Oncol , vol.31 , Issue.5 , pp. 543-550
    • O'Sullivan, B.1    Huang, S.H.2    Siu, L.L.3    Waldron, J.4    Zhao, H.5    Perez-Ordonez, B.6
  • 44
    • 84863307023 scopus 로고    scopus 로고
    • Extracapsular spread and adjuvant therapy in human papillomavirus-related, p16-positive oropharyngeal carcinoma
    • Sinha P., Lewis J.S., Piccirillo J.F., Kallogjeri D., Haughey B.H. Extracapsular spread and adjuvant therapy in human papillomavirus-related, p16-positive oropharyngeal carcinoma. Cancer 2012, 118(14):3519-3530.
    • (2012) Cancer , vol.118 , Issue.14 , pp. 3519-3530
    • Sinha, P.1    Lewis, J.S.2    Piccirillo, J.F.3    Kallogjeri, D.4    Haughey, B.H.5
  • 45
    • 84876412614 scopus 로고    scopus 로고
    • Nodal status is not a prognostic factor in patients with HPV-positive oral/oropharyngeal tumors
    • Klozar J., Koslabova E., Kratochvil V., Salakova M., Tachezy R. Nodal status is not a prognostic factor in patients with HPV-positive oral/oropharyngeal tumors. J Surg Oncol 2013, 107(6):625-633.
    • (2013) J Surg Oncol , vol.107 , Issue.6 , pp. 625-633
    • Klozar, J.1    Koslabova, E.2    Kratochvil, V.3    Salakova, M.4    Tachezy, R.5
  • 46
    • 84888287786 scopus 로고    scopus 로고
    • Phase II trial evaluating axitinib in patients with unresectable, recurrent or metastatic head and neck cancer [Internet]. Available from:
    • Phase II trial evaluating axitinib in patients with unresectable, recurrent or metastatic head and neck cancer [Internet]. Available from: http://www.clinicaltrials.gov/ct2/show/NCT01469546?term=axitinib&rank=14.
  • 47
    • 49249095295 scopus 로고    scopus 로고
    • EGFR, p16, HPV titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer
    • Kumar B., Cordell K.G., Lee J.S., Worden F.P., Prince M.E., Tran H.H., et al. EGFR, p16, HPV titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol 2008, 26(19):3128-3137.
    • (2008) J Clin Oncol , vol.26 , Issue.19 , pp. 3128-3137
    • Kumar, B.1    Cordell, K.G.2    Lee, J.S.3    Worden, F.P.4    Prince, M.E.5    Tran, H.H.6
  • 48
    • 84871918505 scopus 로고    scopus 로고
    • Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes for adoptive immunotherapy of HPV-associated malignancies
    • Ramos C.A., Narala N., Vyas G.M., Leen A.M., Gerdemann U., Sturgis E.M., et al. Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes for adoptive immunotherapy of HPV-associated malignancies. J Immunother 2013, 36(1):66-76.
    • (2013) J Immunother , vol.36 , Issue.1 , pp. 66-76
    • Ramos, C.A.1    Narala, N.2    Vyas, G.M.3    Leen, A.M.4    Gerdemann, U.5    Sturgis, E.M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.